JP2018531578A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531578A5 JP2018531578A5 JP2017560329A JP2017560329A JP2018531578A5 JP 2018531578 A5 JP2018531578 A5 JP 2018531578A5 JP 2017560329 A JP2017560329 A JP 2017560329A JP 2017560329 A JP2017560329 A JP 2017560329A JP 2018531578 A5 JP2018531578 A5 JP 2018531578A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- virus
- influenza
- influenza virus
- attenuated influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2015147703 | 2015-11-06 | ||
| RU2015147703A RU2628690C2 (ru) | 2015-11-06 | 2015-11-06 | Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний |
| PCT/RU2016/050066 WO2017078577A2 (ru) | 2015-11-06 | 2016-11-03 | Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018531578A JP2018531578A (ja) | 2018-11-01 |
| JP2018531578A5 true JP2018531578A5 (enExample) | 2019-10-31 |
| JP6692835B2 JP6692835B2 (ja) | 2020-05-13 |
Family
ID=58662984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017560329A Active JP6692835B2 (ja) | 2015-11-06 | 2016-11-03 | 感染性疾患の予防及び／又は処置並びに腫瘍性疾患の処置のための弱毒化インフルエンザベクター |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10392604B2 (enExample) |
| EP (1) | EP3382010A4 (enExample) |
| JP (1) | JP6692835B2 (enExample) |
| KR (1) | KR102604877B1 (enExample) |
| CN (1) | CN108026515B (enExample) |
| AU (1) | AU2016350939B9 (enExample) |
| CA (1) | CA2991023C (enExample) |
| CU (1) | CU24580B1 (enExample) |
| IL (1) | IL255259B (enExample) |
| MA (1) | MA43314A (enExample) |
| MX (1) | MX380393B (enExample) |
| RU (1) | RU2628690C2 (enExample) |
| SG (1) | SG11201709122VA (enExample) |
| UA (1) | UA125333C2 (enExample) |
| WO (1) | WO2017078577A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018217139A1 (ru) * | 2017-05-26 | 2018-11-29 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новые ингибиторы глутаминилциклаз и их применение для лечения различных заболеваний |
| JP2021508696A (ja) * | 2017-12-22 | 2021-03-11 | コーダ−ジェニックス・インコーポレイテッドＣｏｄａ−Ｇｅｎｉｘ， Ｉｎｃ． | がん処置のためのコドン対脱最適化領域を有する組換え型ウイルス及びその使用法 |
| WO2019172982A1 (en) | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
| US12239699B2 (en) | 2018-09-11 | 2025-03-04 | Shanghai Public Health Clinical Center | Immunogen for broad-spectrum influenza vaccine and application thereof |
| KR102370100B1 (ko) * | 2019-02-15 | 2022-03-07 | 아이디바이오 주식회사 | 이종 인플루엔자 a 바이러스에 대한 면역/치료반응을 형성하는 신규한 재조합 인플루엔자 바이러스 및 이를 포함하는 유전자 전달체 및 치료백신 |
| RU2726106C1 (ru) * | 2019-07-18 | 2020-07-09 | федеральное государственное бюджетное учреждение "Научно-исследовательский институт гриппа имени А.А. Смородинцева" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ гриппа им. А.А. Смородинцева" Минздрава России) | Рекомбинантный штамм вируса гриппа A/PR8-NS124-TB10.4-2A-HspX и способ специфической профилактики туберкулеза легких с использованием вакцины мукозального применения на его основе |
| CN116390748A (zh) * | 2020-09-11 | 2023-07-04 | 佐治亚大学研究基金会股份有限公司 | 用于预防和治疗流感感染的组合物及其使用方法 |
| CN117098553A (zh) * | 2020-11-11 | 2023-11-21 | 加州理工学院 | 多价载体和相关疫苗组合物 |
| CN113430178B (zh) * | 2021-06-21 | 2022-10-11 | 武汉大学 | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 |
| WO2025041889A1 (ko) * | 2023-08-24 | 2025-02-27 | 성신여자대학교 연구산학협력단 | 외래 항원을 발현하는 재조합 인플루엔자 바이러스 벡터 및 이를 포함하는 백신 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK288544B6 (sk) * | 1998-06-12 | 2018-03-05 | Mount Sinai School Of Medicine | Geneticky skonštruovaný oslabený chimérny vírus chrípky, vakcinačný prostriedok a farmaceutický prostriedok s jeho obsahom a ich použitie |
| DE69937999T2 (de) * | 1998-06-12 | 2009-01-29 | Avir Green Hills Biotechnology Research Development Trade Ag | Interferon induzierende genetisch veränderte attenuierte viren |
| US6800288B2 (en) * | 2000-03-02 | 2004-10-05 | Polymun Scientific Immunbiologische Forschung Gmbh | Recombinant influenza A viruses |
| US7037707B2 (en) * | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
| US7709190B2 (en) * | 2005-12-02 | 2010-05-04 | Board Of Regents, The University Of Texas System | Influenza A virus vaccines and inhibitors |
| EP2048237A1 (en) * | 2007-10-05 | 2009-04-15 | Avir Green Hills Biotechnology Research Development Trade Ag | Replication deficient Influenza virus for the expression of heterologous sequences |
| EP2072058A1 (en) * | 2007-12-21 | 2009-06-24 | Avir Green Hills Biotechnology Research Development Trade Ag | Modified influenza virus |
| US9217157B2 (en) * | 2009-07-27 | 2015-12-22 | Icahn School Of Medicine At Mount Sinai | Recombinant influenza viruses and uses thereof |
| US8828406B2 (en) * | 2009-07-30 | 2014-09-09 | Icahn School Of Medicine At Mount Sinai | Influenza viruses and uses thereof |
| WO2011130652A2 (en) * | 2010-04-15 | 2011-10-20 | George Baer | Compositions and methods for vaccinating humans and animals against enveloped viruses |
| WO2011156273A1 (en) * | 2010-06-06 | 2011-12-15 | Mount Sinai School Of Medicine | Recombinant rna viruses and uses thereof |
| JP6069212B2 (ja) * | 2010-12-02 | 2017-02-01 | ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ | ペプチド骨格設計 |
| EP2708552A1 (en) * | 2012-09-12 | 2014-03-19 | Medizinische Universität Wien | Influenza virus |
-
2015
- 2015-11-06 RU RU2015147703A patent/RU2628690C2/ru active
-
2016
- 2016-11-03 CU CU2018000035A patent/CU24580B1/es unknown
- 2016-11-03 JP JP2017560329A patent/JP6692835B2/ja active Active
- 2016-11-03 MX MX2017015462A patent/MX380393B/es unknown
- 2016-11-03 CN CN201680033797.2A patent/CN108026515B/zh active Active
- 2016-11-03 EP EP16862552.3A patent/EP3382010A4/en active Pending
- 2016-11-03 UA UAA201709223A patent/UA125333C2/uk unknown
- 2016-11-03 SG SG11201709122VA patent/SG11201709122VA/en unknown
- 2016-11-03 AU AU2016350939A patent/AU2016350939B9/en active Active
- 2016-11-03 MA MA043314A patent/MA43314A/fr unknown
- 2016-11-03 CA CA2991023A patent/CA2991023C/en active Active
- 2016-11-03 WO PCT/RU2016/050066 patent/WO2017078577A2/ru not_active Ceased
- 2016-11-03 US US15/566,202 patent/US10392604B2/en active Active
- 2016-11-03 KR KR1020177036573A patent/KR102604877B1/ko active Active
-
2017
- 2017-10-25 IL IL255259A patent/IL255259B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015147703A (ru) | Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний | |
| Elkashif et al. | Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections | |
| Wang et al. | Protective efficacy of the conserved NP, PB1, and M1 proteins as immunogens in DNA-and vaccinia virus-based universal influenza A virus vaccines in mice | |
| JP2019537424A5 (enExample) | ||
| Ibañez et al. | M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A | |
| RU2014117068A (ru) | Вакцина на основе рекомбинантных наночастиц f из rsv против респираторно-синцитиального вируса | |
| JP2013518052A5 (enExample) | ||
| Bolduc et al. | The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses | |
| US20230210980A1 (en) | Chimeric adenoviral vectors | |
| TW202430206A (zh) | 組合疫苗 | |
| Lim et al. | RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform | |
| Kesik-Brodacka et al. | A universal flu vaccine | |
| Kopecky-Bromberg et al. | Recombinant vectors as influenza vaccines | |
| Kim et al. | Generation of VHSV replicon particles carrying transmembrane and C-terminal cytoplasmic region-deleted G gene (rVHSV-GΔTM) and comparison of vaccine efficacy with G gene-deleted VHSV (rVHSV-ΔG) | |
| JP7602457B2 (ja) | ペプチド核酸を基盤としたアジュバント | |
| Geeraedts et al. | Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine | |
| Chang et al. | A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus | |
| JP2015527885A (ja) | インフルエンザウイルスの亜型又は株に対するワクチン構築物におけるポックスウイルスエレメントについての組成物、方法及び使用 | |
| EP4284814A2 (en) | Chimeric adenoviral vectors | |
| Attaran et al. | Immunogenicity and protective efficacy of recombinant M2e. Hsp70c (Hsp70359–610) fusion protein against influenza virus infection in mice | |
| US20250049912A1 (en) | Multicistronic Vaccine and Methods for Producing and Using the Same | |
| RU2016111907A (ru) | Аттенуированный гриппозный вектор и мукозальная универсальная гриппозная вакцина на его основе | |
| Ashraf et al. | COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines 2021, 9, 171 | |
| Siddoway | Universal room-temperature stable influenza A nanovaccine | |
| Dong et al. | pter 4 |